Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease

被引:80
作者
Vandenberghe, Rik [1 ,2 ,3 ]
Adamczuk, Katarzyna [1 ,3 ]
Dupont, Patrick [1 ,3 ]
Van Laere, Koen [4 ]
Chetelat, Gael [5 ,6 ,7 ,8 ]
机构
[1] Univ Leuven, Dept Neurosci, Lab Cognit Neurol, Leuven, Belgium
[2] Katholieke Univ Leuven Hosp, Dept Neurol, B-3000 Louvain, Belgium
[3] Univ Leuven, Leuven Inst Neurosci & Dis, KU Leuven, Alzheimer Res Ctr, Leuven, Belgium
[4] Katholieke Univ Leuven Hosp, Dept Nucl Med, B-3000 Louvain, Belgium
[5] INSERM, U1077, Caen, France
[6] Univ Caen Basse Normandie, UMR S1077, Caen, France
[7] Ecole Prat Hautes Etud, UMR S1077, Caen, France
[8] CHU Caen, U1077, F-14000 Caen, France
关键词
Flutemetamol; Florbetapir; Florbetaben; PIB; Clinic; Diagnostic; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; POSTERIOR CORTICAL ATROPHY; GRAY-MATTER LOSS; FLORBETAPIR F 18; IN-VIVO; NATIONAL INSTITUTE; SENILE PLAQUES; F-18-FDG PET; SYNAPSE LOSS;
D O I
10.1016/j.nicl.2013.03.014
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Amyloid imaging is currently introduced to the market for clinical use. We will review the evidence demonstrating that the different amyloid PET ligands that are currently available are valid biomarkers for Alzheimer-related beta amyloidosis. Based on recent findings from cross-sectional and longitudinal imaging studies using different modalities, we will incorporate amyloid imaging into a multidimensional model of Alzheimer's disease. Aside from the critical role in improving clinical trial design for amyloid-lowering drugs, we will also propose a tentative algorithm for when it may be useful in a memory clinic environment. Gaps in our evidence-based knowledge of the added value of amyloid imaging in a clinical context will be identified and will need to be addressed by dedicated studies of clinical utility. (C) 2013 The Authors. Published by Elsevier Inc.
引用
收藏
页码:497 / 511
页数:15
相关论文
共 160 条
[61]   Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET [J].
Herholz, K ;
Salmon, E ;
Perani, D ;
Baron, JC ;
Holthoff, V ;
Frölich, L ;
Schönknecht, P ;
Ito, K ;
Mielke, R ;
Kalbe, E ;
Zündorf, G ;
Delbeuck, X ;
Pelati, O ;
Anchisi, D ;
Fazio, F ;
Kerrouche, N ;
Desgranges, B ;
Eustache, F ;
Beuthien-Baumann, B ;
Menzel, C ;
Schröder, J ;
Kato, T ;
Arahata, Y ;
Henze, M ;
Heiss, WD .
NEUROIMAGE, 2002, 17 (01) :302-316
[62]   Clinical amyloid imaging in Alzheimer's disease [J].
Herholz, Karl ;
Ebmeier, Klaus .
LANCET NEUROLOGY, 2011, 10 (07) :667-670
[63]  
Hodges J., 2001, EARLY ONSET DEMENTIA
[64]   Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways [J].
Hof, PR ;
Vogt, BA ;
Bouras, C ;
Morrison, JH .
VISION RESEARCH, 1997, 37 (24) :3609-3625
[65]   POSTERIOR CORTICAL ATROPHY IN ALZHEIMERS-DISEASE - ANALYSIS OF A NEW CASE AND REEVALUATION OF A HISTORICAL REPORT [J].
HOF, PR ;
ARCHIN, N ;
OSMAND, AP ;
DOUGHERTY, JH ;
WELLS, C ;
BOURAS, C ;
MORRISON, JH .
ACTA NEUROPATHOLOGICA, 1993, 86 (03) :215-223
[66]   In vivo and post-mortem memory circuit integrity in frontotemporal dementia and Alzheimer's disease [J].
Hornberger, Michael ;
Wong, Stephanie ;
Tan, Rachel ;
Irish, Muireann ;
Piguet, Olivier ;
Kril, Jillian ;
Hodges, John R. ;
Halliday, Glenda .
BRAIN, 2012, 135 :3015-3025
[67]   National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease [J].
Hyman, Bradley T. ;
Phelps, Creighton H. ;
Beach, Thomas G. ;
Bigio, Eileen H. ;
Cairns, Nigel J. ;
Carrillo, Maria C. ;
Dickson, Dennis W. ;
Duyckaerts, Charles ;
Frosch, Matthew P. ;
Masliah, Eliezer ;
Mirra, Suzanne S. ;
Nelson, Peter T. ;
Schneider, Julie A. ;
Thal, Dietmar Rudolf ;
Thies, Bill ;
Trojanowski, John Q. ;
Vinters, Harry V. ;
Montine, Thomas J. .
ALZHEIMERS & DEMENTIA, 2012, 8 (01) :1-13
[68]   THE LACK OF ACCUMULATION OF SENILE PLAQUES OR AMYLOID BURDEN IN ALZHEIMERS-DISEASE SUGGESTS A DYNAMIC BALANCE BETWEEN AMYLOID DEPOSITION AND RESOLUTION [J].
HYMAN, BT ;
MARZLOFF, K ;
ARRIAGADA, PV .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (06) :594-600
[69]   Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease [J].
Hyman, BT ;
Trojanowski, JQ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (10) :1095-1097
[70]   Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease [J].
Ikonomovic, Milos D. ;
Klunk, William E. ;
Abrahamson, Eric E. ;
Mathis, Chester A. ;
Price, Julie C. ;
Tsopelas, Nicholas D. ;
Lopresti, Brian J. ;
Ziolko, Scott ;
Bi, Wenzhu ;
Paljug, William R. ;
Debnath, Manik L. ;
Hope, Caroline E. ;
Isanski, Barbara A. ;
Hamilton, Ronald L. ;
DeKosky, Steven T. .
BRAIN, 2008, 131 :1630-1645